Primary Site >> Biliary tract Cancer
Gene >> RUNX3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. PMID: 15447999 Ref: Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients. PMID: 15471559 |
Ref: Restoration of RUNX3 enhances transforming growth factor-beta-dependent p21 expression in a biliary tract cancer cell line. PMID: 17470130 |
Ref: CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma. PMID: 19763613 Ref: DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma. PMID: 19827872 |
Ref: Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis. PMID: 21205092 |
Ref: Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity. PMID: 22446083 |
Ref: Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids. PMID: 23555160 |
Ref: EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3. PMID: 25280519 |
Ref: Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations. PMID: 27009864 |